During a period where U.S. stocks and ETFs are in a slump, S&P Capital IQ’s contrarian ETF portfolio—which is currently outperforming its benchmark index by 150 basis points—has made adjustments in hopes of maintaining its positive momentum, according to an article on Benzinga.

The portfolio is composed of eight ETFs, and was up 11.2 percent through the end of April. The article said the updated contrarian portfolio now includes the following ETFs:

• Vanguard MSCI Emerging Markets ETF (NYSEArca: VWO)
• Vanguard Mid-Cap Growth ETF (NYSEArca: VOT)
• iShares Dow Jones U.S. Oil Equipment Index Fund (NYSEArca: IEZ)

In addition, the S&P contrarian portfolio includes the iShares Dow Jones International Select Dividend Index Fund (NYSEArca: IDV), the First Trust Health Care AlphaDex Fund (NYSEArca: FXH) and the PowerShares S&P 500 High Quality ETF (NYSEArca: SPHQ).

Head over to Benzinga.com to read more.